Hypoxia induces the gene expression and extracellular transmission of persistent lymphocytic choriomeningitis virus

Journal of Virology

Volumn 85, Issue 24, 2011, Pages 13069-13076

  Tomaskova, Jana ^a   Oveckova, Ingrid ^a   Labudova, Martina ^a   Lukacikova, Lubomira ^a   Laposova, Katarina ^a   Kopacek, Juraj ^a   Pastorekova, Silvia ^a   Pastorek, Jaromir ^a  

^a INSTITUTE OF VIROLOGY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS RNA;

ARTICLE; CELL FREE SYSTEM; CONTROLLED STUDY; EXTRACELLULAR SPACE; FEMALE; GENE ACTIVATION; GENE EXPRESSION REGULATION; HELA CELL; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; PROGENY; RNA TRANSCRIPTION; UPREGULATION; VIRION; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS PATHOGENESIS; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

CELL HYPOXIA; GENE EXPRESSION REGULATION, VIRAL; HELA CELLS; HUMANS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS;

LYMPHOCYTIC CHORIOMENINGITIS VIRUS; RNA VIRUSES;

EID: 84855832116     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00829-11     Document Type: Article

References (45)

1. Aghi, M. K., T. C. Liu, S. Rabkin, and R. L. Martuza. 2009. Hypoxia enhances the replication of oncolytic herpes simplex virus. Mol. Ther. 17:51-56.
2. Aprelikova, O., M. Wood, S. Tackett, G. V. Chandramouli, and J. C. Barrett. 2006. Role of ETS transcription factors in the hypoxia-inducible factor-2 target gene selection. Cancer Res. 66:5641-5647.
3. Barton, L. L., and M. B. Mets. 1999. Lymphocytic choriomeningitis virus: pediatric pathogen and fetal teratogen. Pediatr. Infect. Dis. J. 18:540-541.
4. Barton, L. L., M. B. Mets, and C. L. Beauchamp. 2002. Lymphocytic choriomeningitis virus: emerging fetal teratogen. Am. J. Obstet. Gynecol. 187:1715-1716.
5. Borrow, P., and M. B. A. Oldstone. 1997. Lymphocytic choriomeningitis virus, p. 593-627. In N. Nathanson, R. Ahmed, F. Gonzalez-Scarano, D. E. Griffin, K. V. Holmes, F. A. Murphy, and H. L. Robinson (ed.), Viral pathogenesis. Lippincott-Raven, Philadelphia, PA.
6. Buchmeier, M. J., J. C. de La Torre, and C. J. Peters. 2007. Arenaviridae: the viruses and their replication, p. 1793-1826. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 5th ed., vol. II. Lippincott Williams & Wilkins, Philadelphia, PA.
7. Buchmeier, M. J., and A. J. Zajac. 1999. Lymphocytic choriomeningitis virus, p. 575-605. In R. Ahmed and I. S. Y. Chen (ed.), Persistent viral infections. John Wiley & Sons, Chichester, West Sussex, United Kingdom.
8. Cai, Q., et al. 2006. Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: latency control under low-oxygen conditions. J. Virol. 80:7965-7975.
9. Caillet-Fauquet, P., M. L. Draps, M. Di Giambattista, Y. de Launoit, and R. Laub. 2004. Hypoxia enables B19 erythrovirus to yield abundant infectious progeny in a pluripotent erythroid cell line. J. Virol. Methods 121:145-153.
10. Campbell Dwyer, E. J., H. Lai, R. C. MacDonald, M. S. Salvato, and K. L. Borden. 2000. The lymphocytic choriomeningitis virus RING protein Z associates with eukaryotic initiation factor 4E and selectively represses translation in a RING-dependent manner. J. Virol. 74:3293-3300.
11. Charles, S., et al. 2009. Regulation of HIV-1 transcription at 3% versus 21% oxygen concentration. J. Cell. Physiol. 221:469-479.
12. Davis, D. A., et al. 2001. Hypoxia induces lytic replication of Kaposi sarcomaassociated herpesvirus. Blood 97:3244-3250.
13. Fischer, S. A., et al. 2006. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N. Engl. J. Med. 354:2235-2249.
14. Gibadulinova, A., et al. 1998. Sequence and characterisation of the Z gene encoding ring finger protein of the lymphocytic choriomeningitis virus MX strain. Acta Virol. 42:369-374.
15. Haque, M., D. A. Davis, V. Wang, I. Widmer, and R. Yarchoan. 2003. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains hypoxia response elements: relevance to lytic induction by hypoxia. J. Virol. 77:6761-6768.
16. Jaffe, R., E. Jauniaux, and J. Hustin. 1997. Maternal circulation in the first-trimester human placenta-myth or reality? Am. J. Obstet. Gynecol. 176:695-705.
17. Jamieson, D. J., A. P. Kourtis, M. Bell, and S. A. Rasmussen. 2006. Lymphocytic choriomeningitis virus: an emerging obstetric pathogen? Am. J. Obstet. Gynecol. 194:1532-1536.
18. Jiang, J. H., et al. 2006. Hypoxia can contribute to the induction of the Epstein-Barr virus (EBV) lytic cycle. J. Clin. Virol. 37:98-103.
19. Koritzinsky, M., et al. 2006. Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control. EMBO J. 25:1114-1125.
20. Kunz, S., K. H. Edelmann, J. C. de la Torre, R. Gorney, and M. B. Oldstone. 2003. Mechanisms for lymphocytic choriomeningitis virus glycoprotein cleavage, transport, and incorporation into virions. Virology 314:168-178.
21. Labudova, M., J. Tomaskova, M. Kaluzova, J. Pastorek, and S. Pastorekova. 2006. Lymphocytic choriomeningitis virus mx strain does not induce the expression of tumor-associated carbonic anhydrase IX in persistently infected HeLa cells. Acta Virol. 50:53-58.
22. Labudova, M., J. Tomaskova, L. Skultety, J. Pastorek, and S. Pastorekova. 2009. The nucleoprotein of lymphocytic choriomeningitis virus facilitates spread of persistent infection through stabilization of the keratin network. J. Virol. 83:7842-7849.
23. Lee, K. J., I. S. Novella, M. N. Teng, M. B. Oldstone, and J. C. de La Torre. 2000. NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs. J. Virol. 74:3470-3477.
24. Lendahl, U., K. L. Lee, H. Yang, and L. Poellinger. 2009. Generating specificity and diversity in the transcriptional response to hypoxia. Nat. Rev. Genet. 10:821-832.
25. Palacios, G., et al. 2008. A new arenavirus in a cluster of fatal transplantassociated diseases. N. Engl. J. Med. 358:991-998.
26. Pastorekova, S., Z. Zavadova, M. Kostal, O. Babusikova, and J. Zavada. 1992. A novel quasi-viral agent, MaTu, is a two-component system. Virology 187:620-626.
27. Perez, M., and J. C. de la Torre. 2003. Characterization of the genomic promoter of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol. 77:1184-1194.
28. Pestova, T. V., et al. 2001. Molecular mechanisms of translation initiation in eukaryotes. Proc. Natl. Acad. Sci. U. S. A. 98:7029-7036.
29. Pillet, S., et al. 2004. Hypoxia enhances human B19 erythrovirus gene expression in primary erythroid cells. Virology 327:1-7.
30. Puppo, M., M. C. Bosco, M. Federico, S. Pastorino, and L. Varesio. 2007. Hypoxia inhibits Moloney murine leukemia virus expression in activated macrophages. J. Leukoc. Biol. 81:528-538.
31. Reiserova, L., et al. 1999. Identification of MaTu-MX agent as a new strain of lymphocytic choriomeningitis virus (LCMV) and serological indication of horizontal spread of LCMV in human population. Virology 257:73-83.
32. Semenza, G. L. 2001. HIF-1 and mechanisms of hypoxia sensing. Curr. Opin. Cell Biol. 13:167-171.
33. Semenza, G. L. 2009. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology (Bethesda) 24:97-106.
34. Semenza, G. L. 2003. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3:721-732.
35. Servais, C., et al. 2006. Hypoxic-response elements in the oncolytic parvovirus minute virus of mice do not allow for increased vector production at low oxygen concentration. J. Gen. Virol. 87:1197-1201.
36. Shen, B. H., M. Bauzon, and T. W. Hermiston. 2006. The effect of hypoxia on the uptake, replication and lytic potential of group B adenovirus type 3 (Ad3) and type 11p (Ad11p). Gene Ther. 13:986-990.
37. Tomaskova, J., M. Labudova, J. Kopacek, S. Pastorekova, and J. Pastorek. 2008. Molecular characterization of the genes coding for glycoprotein and L protein of lymphocytic choriomeningitis virus strain MX. Virus Genes 37:31-38.
38. van der Zeijst, B. A., et al. 1983. Persistent infection of some standard cell lines by lymphocytic choriomeningitis virus: transmission of infection by an intracellular agent. J. Virol. 48:249-261.
39. Volpon, L., M. J. Osborne, A. A. Capul, J. C. de la Torre, and K. L. Borden. 2010. Structural characterization of the Z RING-eIF4E complex reveals a distinct mode of control for eIF4E. Proc. Natl. Acad. Sci. U. S. A. 107:5441-5446.
40. von der Haar, T., J. D. Gross, G. Wagner, and J. E. McCarthy. 2004. The mRNA cap-binding protein eIF4E in post-transcriptional gene expression. Nat. Struct. Mol. Biol. 11:503-511.
41. Washington, A. T., G. Singh, and A. Aiyar. 2010. Diametrically opposed effects of hypoxia and oxidative stress on two viral transactivators. Virol. J. 7:93.
42. Welsh, R. 2008. Lymphocytic choriomeningitis virus: general features, p. 238-243. In B. W. J. Mahy and M. H. V. van Regenmortel (ed.), Encyclopedia of virology, 3rd ed. Academic Press, Amsterdam, The Netherlands.
43. Welsh, R. M. 2000. Lymphocytic choriomeningitis virus as a model for the study of cellular immunology, p. 289-312. In M. W. Cunningham and R. S. Fujinami (ed.), Effects of microbes on the immune system. Lippincott Williams & Wilkins, Philadelphia, PA.
44. Wright, R., et al. 1997. Congenital lymphocytic choriomeningitis virus syndrome: a disease that mimics congenital toxoplasmosis or cytomegalovirus infection. Pediatrics 100:E9.
45. Zinkernagel, R. M., and P. C. Doherty. 1977. Major transplantation antigens, viruses, and specificity of surveillance T cells. Contemp. Top. Immunobiol 7:179-220.